Related Experiment Video
Updated: Mar 20, 2026

Measurements of Physiological Stress Responses in C. Elegans
Published on: May 21, 2020
Insights into the Stress Response Triggered by Kasugamycin in Escherichia coli
Christian Müller1, Lena Sokol2, Oliver Vesper3
1Max F. Perutz Laboratories, Center for Molecular Biology, Department of Microbiology, Immunobiology and Genetics, University of Vienna, Vienna Biocenter (VBC), Dr. Bohr-Gasse 9/4, A-1030 Vienna, Austria. christian_mueller@univie.ac.at.
Abstract:
The bacteriostatic aminoglycoside antibiotic kasugamycin inhibits protein synthesis at an initial step without affecting translation elongation. It binds to the mRNA track of the ribosome and prevents formation of the translation initiation complex on canonical mRNAs. In contrast, translation of leaderless mRNAs continues in the presence of the drug in vivo. Previously, we have shown that kasugamycin treatment in E. coli stimulates the formation of protein-depleted ribosomes that are selective for leaderless mRNAs. Here, we provide evidence that prolonged kasugamycin treatment leads to selective synthesis of specific proteins. Our studies indicate that leaderless and short-leadered mRNAs are generated by different molecular mechanisms including alternative transcription and RNA processing. Moreover, we provide evidence for ribosome heterogeneity in response to kasugamycin treatment by alteration of the modification status of the stalk proteins bL7/L12.
Insights
Kasugamycin antibiotic selectively synthesizes proteins by promoting protein-depleted ribosomes that translate leaderless mRNAs. This occurs through altered ribosome modification and distinct mRNA generation mechanisms.
Area of Science:
- Molecular Biology
- Microbiology
- Genetics
Background:
- Kasugamycin is a bacteriostatic antibiotic that inhibits protein synthesis by targeting the ribosome's mRNA track.
- It specifically blocks translation initiation on canonical mRNAs but not on leaderless mRNAs.
- Previous work showed kasugamycin induces protein-depleted ribosomes selective for leaderless mRNAs in E. coli.
Purpose of the Study:
- To investigate the mechanisms behind selective protein synthesis during prolonged kasugamycin treatment.
- To explore the generation of leaderless and short-leadered mRNAs.
- To examine ribosome heterogeneity in response to kasugamycin.
Main Methods:
- Bacterial culture and treatment with kasugamycin.
- Analysis of mRNA populations (leaderless, short-leadered, canonical).
- Ribosome profiling and characterization of ribosome composition and modification status.
Main Results:
- Prolonged kasugamycin treatment leads to the selective synthesis of specific proteins.
- Leaderless and short-leadered mRNAs are generated via distinct mechanisms, including alternative transcription and RNA processing.
- Evidence of ribosome heterogeneity was observed, linked to altered modification of stalk proteins (bL7/L12).
Conclusions:
- Kasugamycin induces selective protein synthesis by altering ribosome populations and mRNA accessibility.
- The generation of specific mRNA types and ribosome heterogeneity are key responses to kasugamycin.
- Ribosome stalk protein modification plays a role in kasugamycin-induced translational control.
Related Concept Videos
Stringent Response in E. coli
Other Stress Responses in Bacteria
Bacterial Gastroenteritis
Development of Antibiotic Resistance
Global Regulatory Systems

